Page last updated: 2024-10-27

flumazenil and Bone Diseases, Developmental

flumazenil has been researched along with Bone Diseases, Developmental in 2 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Bone Diseases, Developmental: Diseases resulting in abnormal GROWTH or abnormal MORPHOGENESIS of BONES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Siccha, SM1
Cueto, AM1
Parrón-Pajares, M1
González-Morán, G1
Pacio-Miguez, M1
Del Pozo, Á1
Solís, M1
Rodriguez-Jimenez, C1
Caino, S1
Fano, V1
Heath, KE1
García-Miñaúr, S1
Palomares-Bralo, M1
Santos-Simarro, F1
López de la Torre Casares, M1
Rodríguez Poyo-Guerrero, P1
Gargallo Fernández, M1
Moreno Esteban, B1
Jara Albarrán, A1

Reviews

1 review available for flumazenil and Bone Diseases, Developmental

ArticleYear
Delineation of the clinical and radiological features of Stuve-Wiedemann syndrome childhood survivors, four new cases and review of the literature.
    American journal of medical genetics. Part A, 2021, Volume: 185, Issue:3

    Topics: Abnormalities, Multiple; Bone Diseases, Developmental; Bone Diseases, Metabolic; Child, Preschool; C

2021

Other Studies

1 other study available for flumazenil and Bone Diseases, Developmental

ArticleYear
[Infantile appearance at age l6 in a girl with hypothyroidism and total situs inversus].
    Anales espanoles de pediatria, 1989, Volume: 31, Issue:2

    Topics: Abnormalities, Multiple; Adolescent; Bone Diseases, Developmental; Congenital Hypothyroidism; Growth

1989